128 related articles for article (PubMed ID: 36535926)
21. The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1.
Yu W; Singh R; Wang Z; O'Malley BW; Yi P
J Biol Chem; 2021; 296():100739. PubMed ID: 33991522
[TBL] [Abstract][Full Text] [Related]
22. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
24. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.
Pai S; Yadav VK; Kuo KT; Pikatan NW; Lin CS; Chien MH; Lee WH; Hsiao M; Chiu SC; Yeh CT; Tsai JT
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768921
[No Abstract] [Full Text] [Related]
25. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
[TBL] [Abstract][Full Text] [Related]
26. Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib.
Lang L; Lam T; Chen A; Jensen C; Duncan L; Kong FC; Kurago ZB; Shay C; Teng Y
Cells; 2020 Feb; 9(3):. PubMed ID: 32106632
[TBL] [Abstract][Full Text] [Related]
27. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.
Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355
[TBL] [Abstract][Full Text] [Related]
28. TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling.
Iyengar PV; Marvin DL; Lama D; Tan TZ; Suriyamurthy S; Xie F; van Dinther M; Mei H; Verma CS; Zhang L; Ritsma L; Ten Dijke P
Mol Cancer Res; 2022 Oct; 20(10):1516-1531. PubMed ID: 35731212
[TBL] [Abstract][Full Text] [Related]
29. Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy.
Chen H; Qian Z; Zhang S; Tang J; Fang L; Jiang F; Ge D; Chang J; Cao J; Yang L; Cao X
Redox Biol; 2021 Jan; 38():101774. PubMed ID: 33152664
[TBL] [Abstract][Full Text] [Related]
30. The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation.
Matsuoka Y; Yoshida R; Kawahara K; Sakata J; Arita H; Nkashima H; Takahashi N; Hirayama M; Nagata M; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2022 Aug; 102(8):896-907. PubMed ID: 35414650
[TBL] [Abstract][Full Text] [Related]
31. TRAF4 knockdown triggers synergistic lethality with simultaneous PARP1 inhibition in endometrial cancer.
Tang L; Wang M; Jiang L; Zeng C
Hum Cell; 2020 Jul; 33(3):801-809. PubMed ID: 32388810
[TBL] [Abstract][Full Text] [Related]
32. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
33. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
34. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
[TBL] [Abstract][Full Text] [Related]
35. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation.
Li S; Lu K; Wang J; An L; Yang G; Chen H; Cui Y; Yin X; Xie P; Xing G; He F; Zhang L
Mol Cell Biochem; 2010 May; 338(1-2):11-7. PubMed ID: 19937093
[TBL] [Abstract][Full Text] [Related]
38. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
[TBL] [Abstract][Full Text] [Related]
39. Bergenin Inhibits Tumor Growth and Overcomes Radioresistance by Targeting Aerobic Glycolysis.
Li X; Xie L; Zhou L; Gan Y; Han S; Zhou Y; Qing X; Li W
Am J Chin Med; 2023; 51(7):1905-1925. PubMed ID: 37646142
[TBL] [Abstract][Full Text] [Related]
40. Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z; Curran WJ; Deng X
Cancer Res; 2019 Dec; 79(24):6126-6138. PubMed ID: 31662324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
